Trial NCT04495010

View at ClinicalTrials.gov 
Org. Study IDs: CA209-7UA
Secondary IDs: 2020-000070-16

Last trial update was posted on 2021-03-19

MeSH Interventions

Ipilimumab Nivolumab

MeSH Conditions

Melanoma

Other Conditions


Stopping Reasons

Business objectives have changed

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID